Dr Robin Chan

Dr Robin Chan is the Scientific Director of the Singapore Translational Cancer Consortium (STCC). He supports the development and coordination of collaborative, investigator-led cancer research across Singapore’s public healthcare and academic institutions.

Dr Chan received his PhD in Biochemistry and completed his academic training at the National University of Singapore and Columbia University Medical Center. He has over 15 years of experience spanning academic research and the biotechnology industry, with expertise in multi-omics analysis and translational biology in neurodegeneration, infectious diseases and oncology. Prior to joining STCC, he held senior scientific and strategic roles in biotechnology, where he led the development of multi-omics research platforms and cross-institutional academic–industry collaborations.

At STCC, Dr Chan's work focuses on strengthening translational research platforms, supporting investigator-initiated studies, and fostering strategic partnerships that bridge healthcare institutions, academia, and industry. He is committed to enabling high-quality, clinically relevant research and supporting clinician-scientists in translating scientific discoveries into meaningful patient impact.